One third of all lung cancer patients are diagnosed in emergency clinics, which is significantly higher than for any other cancer.
In 2015, lung cancer experts called for action on tackling emergency presentation of lung cancer, launching a high profile report and series of recommendations at a British Lung Foundation (BLF) Parliamentary event.
Lung cancer is the UK’s biggest cancer killer, accounting for one in five of all cancer deaths. Survival rates in this country lag behind those in Europe and the US, with just one in ten patients in the UK surviving for five years post-diagnosis. This is the devastating effect of late presentation and diagnosis.
The UKLS pilot screening trial, which was the first lung cancer screen trial to take place in the UK was aimed to benefit people who are at risk of developing lung cancer. The UKLS trial provides in depth information on how to set up a national lung cancer CT screening programme, including using a risk prediction model to identify high risk individuals in the population, use of volumetric analysis of CT detected nodules and a pathway for the management of indeterminate nodules.
0.5 CPD credit
Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate.
You must login to watch the video and receive CPD.
Professor and Chairman of Radiology at Translational Lung Research Center Heidelberg
Scientific Coordinator of the Platform Imaging of the German Center for Lung Research (DZL)
Deputy-Speaker of the Translational Lung Research Center (TLRC)
Medical Director, Department of Diagnostic and Interventional Radiology
Professor Kauczor has been working closely with the Heidelberg Hospital since 2003 as the head of the Department of Radiology at the German Cancer Research Centre (DKFZ) in Heidelberg. He is also Professor and Chairman of Radiology, Scientific Coordinator of the Platform Imaging of the German Center for Lung Research (DZL).
Professor Kauczor’s scientific work is mainly focused on the accurate and early detection of malignant tumours using innovative methods such as magnetic resonance tomography (MRT) and computer tomography (CT).